Drop for reducing eye redness
Part of Eyes & vision clinical trials.
This study tests an experimental eye drop to see if it reduces eye redness better than a placebo (inactive) drop. If you often have red eyes and want a new option, this may be a good fit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have used redness relief eye drops recently (in the past 6 months) or are interested in trying over-the-counter redness relief drops.
- You have noticeable eye redness (a score of 0.5 or higher in at least one eye at the first visit, and more than 1 unit in both eyes at the second visit).
- You have not had eye surgery within the last 6 months.
- You do not have any eye condition that would make it unsafe to participate.
- Your blood pressure and pulse are within normal range (or controlled with medication).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new eye drop called FID 123472 to see how well it reduces redness in adults. If you have persistent eye redness and have used redness relief drops before, this trial might help you find a longer-lasting solution.
This trial tests if adding brimonidine eye drops can reduce eye redness caused by the glaucoma drops you are currently taking. It may help if you have been using netarsudil/latanoprost drops and have noticed redness.
This study tests a new eye drop that aims to reduce redness in people with dry eye disease. It may help if you have dry eyes and noticeable redness.
This study tests a red-eye relief drop called Lumify (brimonidine tartrate) in people with glaucoma who are already using brimonidine. It looks at whether Lumify changes eye redness, eye pressure, and eyelid position.
This trial tests an eye drop called Daydrop Triple Action to see if it helps with eye itching and redness caused by allergies. It might be a good option if you have allergic conjunctivitis and have not used other allergy eye medications recently.
This study tests an experimental eye drop for people with dry eye disease. It aims to see if the drops can reduce symptoms and signs of dry eye.
Hear when a new Ocular Hyperemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.